share_log
Benzinga ·  07/23 08:00

EXCLUSIVE: Adial Pharmaceuticals Tells Benzinga 'Patient Dosing in the Second Cohort Has Commenced Following the Successful Completion of the First Cohort'

独家:adial pharmaceuticals告诉Benzinga:“第二组患者的服药量开始了,第一组的治疗成功结束。”

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发